Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Nuvalent Details Strategy to Seek First Potential Approval in 2026 and Outlines Key Anticipated 2025 Milestones PR Newswire CAMBRIDGE, Mass., Jan. 13, 2025 Strategy prioritizes most accelerated...
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.125 | -1.46170337166 | 76.965 | 78.1785 | 69.58 | 662000 | 74.32991547 | CS |
| 4 | -7.965 | -9.50420619295 | 83.805 | 87.315 | 69.58 | 557053 | 78.40622322 | CS |
| 12 | -17.82 | -19.0262652146 | 93.66 | 97.65 | 69.58 | 468480 | 86.16479745 | CS |
| 26 | -6.54 | -7.93882010197 | 82.38 | 113.51 | 64.67 | 460468 | 90.45302561 | CS |
| 52 | 2.92 | 4.00438837082 | 72.92 | 113.51 | 61.795 | 445157 | 83.11298963 | CS |
| 156 | 63.51 | 515.085158151 | 12.33 | 113.51 | 7.09 | 362182 | 57.86705977 | CS |
| 260 | 57.74 | 319.005524862 | 18.1 | 113.51 | 7.09 | 333778 | 55.90656108 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
